OLUMIUS

EUIPO EUIPO 2014 Trademark registered

The displayed mark can be extended.
Click here, to extend trademark protection for a further 10 years.

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark OLUMIUS was filed as Word mark on 12/15/2014 at the European Union Intellectual Property Office.
It was registered as a trademark on 06/10/2015. The current status of the mark is "Trademark registered".

Extend brand

Trademark Details Last update: June 17, 2024

Trademark form Word mark
File reference 013574702
Application date December 15, 2014
Publication date March 3, 2015
Entry date June 10, 2015
Expiration date December 15, 2024

Trademark owner

Lilly Corporate Center
46285 Indianapolis,
US

Trademark representatives

Widenmayerstr. 10 80538 München DE

goods and services

5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, reproductive system diseases and disorders, sleep disorders; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of urological disorders; antidepressants; pharmaceutical preparations; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Trademark history

Date Document number Area Entry
May 19, 2024 Extension, Notification of expiry of trade mark
April 5, 2019 Change Representative, Published
December 20, 2018 Change Representative, Published

ID: 11013574702